The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
MPTP Mouse Models of Parkinson's Disease: An Update
Open accessAbstract
Among the most widely used models of Parkinson's disease (PD) are those that employ toxins, especially 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Depending on the protocol used, MPTP yields large variations in nigral cell loss, striatal dopamine loss and behavioral deficits. Motor deficits do not fully replicate those seen in PD. Nonetheless, MPTP mouse models mimic many aspects of the disease and are therefore important tools for understanding PD. In this review, we will discuss the ability of MPTP mouse models to replicate the pathophysiology of PD, the mechanisms of MPTP-induced neurotoxicity, strain differences in susceptibility to MPTP, and the models' roles in testing therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,376
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death
Joza, N., Susin, S. A., Daugas, E., Stanford, W. L., Cho, S. K., Li, C. Y. J., Sasaki, T., Elia, A. J., Cheng, H.-Y. M., Ravagnan, L., et al. (2001) · Nature · doi:10.1038/35069004 · Cited by 1,366
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., & Peterson, P. K. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2736 · Cited by 1,136
Autoactivation of Procaspase-9 by Apaf-1-Mediated Oligomerization
Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., & Alnemri, E. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80095-7 · Cited by 1,119
Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity
Zhang, J., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1994) · Science · doi:10.1126/science.8080500 · Cited by 1,118
Protocol for the MPTP mouse model of Parkinson's disease
Jackson-Lewis, V., & Przedborski, S. (2007) · Nature Protocols · doi:10.1038/nprot.2006.342 · Cited by 1,111
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 1×
“The expression of iNOS in activated microglia contributes to the death of DAergic neurons in MPTP toxicity [67, 68].”
BackgroundBanati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,029
Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
Heikkila, R. E., Hess, A., & Duvoisin, R. C. (1984) · Science · doi:10.1126/science.6610213 · Cited by 1,009
Cellular Defenses against Unfolded Proteins
Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 991
Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 971
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
Self-citationDu, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis
Daugas, E., Susin, S. A., Zamzami, N., Ferri, K. F., Irinopoulou, T., Larochette, N., Prévost, M., Leber, B., Andrews, D., Penninger, J., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.729 · Cited by 776
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
Pathological implications of nitric oxide, superoxide and peroxynitrite formation
Beckman, J. S., & Crow, J. P. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210330 · Cited by 673
Origin and functional consequences of the complex I defect in Parkinson's disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638
Przedborski, S., Jackson-Lewis, V, Yokoyama, R., Shibata, T., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4565 · Cited by 624
Jackson-Lewis, V., Jakowec, M., Burke, R. E., & Przedborski, S. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90015-2 · Cited by 609
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology · doi:10.1002/ana.20186 · Cited by 548
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists
Turski, L., Bressler, K., Jürgen Rettig, K., Löschmann, P.-A., & Wachtel, H. (1991) · Nature · doi:10.1038/349414a0 · Cited by 546
Fornai, F., Schlüter, O. M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C. L., Pontarelli, F., Battaglia, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409713102 · Cited by 526
Gerlach, M., & Riederer, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 498
Dawson, V. L., & Dawson, T. M. (1996) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(96)00148-2 · Cited by 498
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slechta, D. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
Halliwell, B. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01779.x · Cited by 469
Tatton, N. A., & Kish, S. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00545-3 · Cited by 468
Animal models of neurological deficits: how relevant is the rat?
Cenci, M. A., Whishaw, I. Q., & Schallert, T. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn877 · Cited by 456
Przedborski, S., Kostic, V, Jackson-Lewis, V, Naini, A., Simonetti, S., Fahn, S., Carlson, E., Epstein, C., & Cadet, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456
Parkinson's--Divergent Causes, Convergent Mechanisms
Greenamyre, J. T., & Hastings, T. G. (2004) · Science · doi:10.1126/science.1098966 · Cited by 451
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons
Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., & Beal, M. F. (1996) · Nature Medicine · doi:10.1038/nm0996-1017 · Cited by 422
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 390
Vila, M., Vukosavic, S., Jackson‐Lewis, V., Neystat, M., Jakowec, M., & Przedborski, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740721.x · Cited by 388
Mandir, A. S., Przedborski, S., Jackson-Lewis, V., Wang, Z.-Q., Simbulan-Rosenthal, C. M., Smulson, M. E., Hoffman, B. E., Guastella, D. B., Dawson, V. L., & Dawson, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5774 · Cited by 382
Animal Models of Action Tremor
Elble, R. J. (2008) · Movement Disorders · doi:10.1002/mds.870131306 · Cited by 380
Kurkowska-Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379
Breidert, T., Callebert, J., Heneka, M. T., Landreth, G., Launay, J. M., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00990.x · Cited by 373
Energy Thresholds in Brain Mitochondria
Davey, G. P., Peuchen, S., & Clark, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12753 · Cited by 361
Gainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353
Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · cited 6×
“Importantly, MPP+ induces the opening of the mitochondrial transition pore through the inhibition of complex I and the production of ROS [38].”
BackgroundInfluentialCritical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Liu, B., & Hong, J.-S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06181.2003 · Cited by 337
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337
A simple quantitative bradykinesia test in MPTP-treated mice.
Ogawa, N., Hirose, Y., Ohara, S., Ono, T., & Watanabe, Y. (1985) · PubMed · Cited by 334
Petroske, E., Meredith, G. E., Callen, S., Totterdell, S., & Lau, Y.-S. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00295-0 · Cited by 331
Self-citationViswanath, V., Wu, Y., Boonplueang, R., Chen, S., Stevenson, F. F., Yantiri, F., Yang, L., Beal, M. F., & Andersen, J. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09519.2001 · Cited by 315
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage
Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., & Vila, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508215102 · Cited by 308
Cassarino, D. S., Parks, J. K., Parker, W. D., & Bennett, J. P. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00083-0 · Cited by 304
Hallman, H., Lange, L., Olson, L., Strömberg, I., & Jonsson, G. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07120.x · Cited by 281
The microglial cell. A historical review
Barron, K. D. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00209-k · Cited by 280
Rozas, G., Guerra, M. J., & Labandeira-Garcı́a, J. L. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(97)00034-2 · Cited by 275
Le, W.-D., Rowe, D., Xie, W., Ortiz, I., He, Y., & Appel, S. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08447.2001 · Cited by 275
Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism
Tatton, W. G., & Greenwood, C. E. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300410 · Cited by 272
. Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J., & Son, J. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00096.x · Cited by 256
Sedelis, M., Hofele, K., Auburger, G. W., Morgan, S., Huston, J. P., & Schwarting, R. K. W. (2000) · Behavior Genetics · doi:10.1023/a:1001958023096 · Cited by 252
The parkinsonian toxin MPTP: action and mechanism
Przedborski, S., Jackson-Lewis, V., Djaldetti, R., Liberatore, G., Vila, M., Vukosavic, S., & Almer, G. (2000) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2000-00132 · Cited by 252
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Meredith, G. E., & Kang, U. J. (2006) · Movement Disorders · doi:10.1002/mds.21010 · Cited by 250
Self-citationRapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain
Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., & Di Monte, D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02134.x · Cited by 241
Muralikrishnan, D., & Mohanakumar, K. P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.905 · Cited by 237
Animal models of Parkinson’s disease progression
Meredith, G. E., Sonsalla, P. K., & Chesselet, M.-F. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0350-x · Cited by 228
Self-citationMeredith, G. E., Totterdell, S., Petroske, E., Santa Cruz, K., Callison, R. C., & Lau, Y.-S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03514-x · Cited by 212
Self-citationNedergaard, S., Flatman, J. A., & Engberg, I. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019742 · Cited by 211
The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice
Sonsalla, P. K., & Heikkila, R. E. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90444-9 · Cited by 211
Forno, L. S., DeLanney, L. E., Irwin, I., & Langston, J. W. (1993) · PubMed · Cited by 207
Sunstro¨m, E., Stro¨mberg, I., Tsutsumi, T., Olson, L., & Jonsson, G. (1987) · Brain Research · doi:10.1016/0006-8993(87)90986-3 · Cited by 204
Ramsay, R. R., Dadgar, J., Trevor, A., & Singer, T. P. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90037-8 · Cited by 181
Ricaurte, G. A., William Langston, J., Delanney, L. E., Irwin, I., Peroutka, S. J., & Forno, L. S. (1986) · Brain Research · doi:10.1016/0006-8993(86)90905-4 · Cited by 180
Perry, T. L., Yong, V. W., Clavier, R. M., Jones, K., Wright, J. M., Foulks, J. G., & Wall, R. A. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90229-0 · Cited by 177
Dedon, P. C., Plastaras, J. P., Rouzer, C. A., & Marnett, L. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11113 · Cited by 176
Luchtman, D. W., Shao, D., & Song, C. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.04.021 · Cited by 167
Mochizuki, H., Hayakawa, H., Migita, M., Shibata, M., Tanaka, R., Suzuki, A., Shimo-Nakanishi, Y., Urabe, T., Yamada, M., Tamayose, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191107398 · Cited by 164
Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons
Yang, L., Sugama, S., Chirichigno, J. W., Gregorio, J., Lorenzl, S., Shin, D. H., Browne, S. E., Shimizu, Y., Joh, T. H., Beal, M. F., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10709 · Cited by 158
Age-related susceptibility to MPTP-induced neurotoxicity in mice.
Ali, S. F., David, S. N., & Newport, G. D. (1993) · PubMed · Cited by 152
Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity
Monte, D. A. D., Sandy, M. S., Ekström, G., & Smith, M. T. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)91210-6 · Cited by 145
Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones
Mercuri, N. B., Bond, A., Calabresi, P., Stratta, F., Stefani, A., & Bernardi, G. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17068.x · Cited by 143
Muthane, U. B., Ramsay, K., Jiang, H., Jackson-Lewis, V. R., Donaldson, D. M., Fernando, S., Ferreira, M., & Przedborski, S. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1058 · Cited by 143
Furuya, T., Hayakawa, H., YAMADA, M., Yoshimi, K., Hisahara, S., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3309-03.2004 · Cited by 140
Gibrat, C., Saint‐Pierre, M., Bousquet, M., Lévesque, D., Rouillard, C., & Cicchetti, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06072.x · Cited by 136
Chadi, G., Er, A., Rosén, L., Janson, A. M., Agnati, L. A., Goldstein, M., Ögren, S. O., Pettersson, R. F., & Fuxé, K. (1993) · Experimental Brain Research · doi:10.1007/bf00228825 · Cited by 133
German, D. C., Nelson, E. L., Liang, C., Speciale, S. G., Sinton, C. M., & Sonsalla, P. K. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0041 · Cited by 132
Hamre, K., Tharp, R., Poon, K. K.-Y., Xiong, X., & Smeyne, R. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01273-1 · Cited by 132
Meredith, G. E., Totterdell, S., Beales, M., & Meshul, C. K. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.06.005 · Cited by 132
Self-citationAli, S. F., David, S. N., Newport, G. D., Cadet, J. L., & Slikker, W. (1994) · Synapse · doi:10.1002/syn.890180105 · Cited by 124
Sonsalla, P. K., Zeevalk, G. D., Manzino, L., Giovanni, A., & Nicklas, W. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10081.x · Cited by 119
Rozas, G., & Labandeira-García, J. L. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01162-6 · Cited by 114
Arai, N., Misugi, K., Goshima, Y., & Misu, Y. (1990) · Brain Research · doi:10.1016/0006-8993(90)90576-w · Cited by 110
Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism
Sonsalla, P. K., Albers, D. S., & Zeevalk, G. D. (1998) · Amino Acids · doi:10.1007/bf01345245 · Cited by 110
Obata, T., & Chiueh, C. C. (1992) · Journal of Neural Transmission · doi:10.1007/bf01245361 · Cited by 106
Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease
Shimoji, M., Zhang, L., Mandir, A. S., Dawson, V. L., & Dawson, T. M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.01.012 · Cited by 104
Novikova, L., Garris, B. L., Garris, D. R., & Lau, Y.-S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.007 · Cited by 95
Kupsch, A. R., Gerlach, M., Pupeter, S. C., Sautter, J., Dirr, A., Arnold, G., Opitz, W., Przuntek, H., Riederer, P. F., & Oertel, W. H. (1995) · Neuroreport · doi:10.1097/00001756-199503000-00009 · Cited by 87
Cosi, C., & Marien, M. R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00829-4 · Cited by 86
Inoue, H., Castagnoli, K., der Schyf, C. V., Mabic, S., Igarashi, K., & Castagnoli, N. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35176-6 · Cited by 82
Hazell, A. S., Itzhak, Y., Liu, H., & Norenberg, M. D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052216.x · Cited by 80
Blume, S. R., Cass, D. K., & Tseng, K. Y. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.017 · Cited by 76
Zang, L., & Misra, H. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85448-0 · Cited by 75
Rat model of Parkinson's disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)
Yazdani, U., German, D. C., Liang, C., Manzino, L., Sonsalla, P. K., & Zeevalk, G. D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.002 · Cited by 73
Effect of MPTP and l ‐Deprenyl on Antioxidant Enzymes and Lipid Peroxidation Levels in Mouse Brain
Thiffault, C., Aumont, N., Quirion, R., & Poirier, J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062725.x · Cited by 73
Lin, S., Wei, X., Xu, Y., Yan, C., Dodel, R., Zhang, Y., Liu, J., Klaunig, J. E., Farlow, M., & Du, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02442-6 · Cited by 70
Cosi, C., & Marien, M. R. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07998.x · Cited by 70
Meredith, G. E., Halliday, G. M., & Totterdell, S. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.001 · Cited by 66
Self-citationSelective alterations of gene expression in mice induced by MPTP
Xu, Z., Cawthon, D., McCastlain, K., Slikker, W., & Ali, S. F. (2004) · Synapse · doi:10.1002/syn.20089 · Cited by 62
Schwarting, R. K. W., Sedelis, M., Hofele, K., Auburger, G. W. J., & Huston, J. P. (1999) · Neurotoxicity Research · doi:10.1007/bf03033338 · Cited by 57
JANSON, A. M., FUXE, K., SUNDSTRÖM, E., AGNATI, L. F., & GOLDSTEIN, M. (1988) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1988.tb08372.x · Cited by 56
Womer, D. E., Jones, B. C., & Erwin, V. G. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90534-7 · Cited by 55
Riachi, N. J., & Harik, S. I. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90189-0 · Cited by 54
(+)MK-801 Does Not Prevent MPTP-Induced Loss of Nigral Neurons in Mice
Chan, P., Monte, D. A. D., Langston, J. W., & Janson, A. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36409-2 · Cited by 52
Chan, P., Langston, J. W., Irwin, I., DeLanney, L. E., & Monte, D. A. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02165.x · Cited by 49
Goldberg, N. R. S., Haack, A. K., Lim, N. S., Janson, O. K., & Meshul, C. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.027 · Cited by 49
Andrews, A. M., Ladenheim, B., Epstein, C. J., Cadet, J. L., & Murphy, D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09609-9 · Cited by 45
Obata, T., Yamanaka, Y., Kinemuchi, H., & Oreland, L. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02238-7 · Cited by 44
Kilbourn, M. R., & Frey, K. A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00252-x · Cited by 44
Nifedipine blocks apamin-induced bursting activity in nigral dopamine-containing neurons
Shepard, P. D., & Stump, D. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01231-1 · Cited by 43
In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists
Santiago, M., Venero, J. L., Machado, A., & Cano, J. (1992) · Brain Research · doi:10.1016/0006-8993(92)91628-r · Cited by 39
McNaught, K. S. P., Thull, U., Carrupt, P., et al. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00091-3 · Cited by 38
Kurkowska‐Jastrzębska, I., Bałkowiec-Iskra, E., Ciesielska, A., Joniec‐Maciejak, I., Cudna, A., Zaremba, M., Członkowski, A., & Członkowska, A. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.03.003 · Cited by 36
Andrews, A. M., & Murphy, D. L. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03271.x · Cited by 35
Sayre, L. M., Wang, F., & Hoppel, C. L. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92672-7 · Cited by 34
MPTP and aging. Studies in the C57BL/6 mouse.
Irwin, I., Le, D., & Jw, L. (1993) · PubMed · Cited by 33
Sedelis, M., Hofele, K., Auburger, G. W. J., Morgan, S., Huston, J. P., & Schwarting, R. K. W. (2000) · Neuroreport · doi:10.1097/00001756-200004070-00037 · Cited by 30
Sedelis, M., Hofele, K., Schwarting, R. K. W., Huston, J. P., & Belknap, J. K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08247.2003 · Cited by 27
Antiparkinsonian Drugs and Their Neuroprotective Effects.
Kitamura, Y., Kakimura, J., & Taniguchi, T. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.284 · Cited by 26
Andersen, J. K., Frim, D. M., Isacson, O., et al. (1994) · Brain Research · doi:10.1016/0006-8993(94)91371-4 · Cited by 22
Book Review: Forced Limb-Use and Recovery following Brain Injury
Tillerson, J. L., & Miller, G. W. (2002) · The Neuroscientist · doi:10.1177/1073858402238516 · Cited by 21
Accumulation of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Cultured Cerebellar Astrocytes
Marini, A. M., Lipsky, R. H., Schwartz, J. P., & Kopin, I. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11336.x · Cited by 21
Festing, M. F. W. (1991) · Cellular and Molecular Life Sciences · doi:10.1007/bf01923334 · Cited by 20
Andrews, A. M., & Murphy, D. L. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39594-7 · Cited by 20
Donnan, G. A., Kaczmarczyk, S., Solopotias, T., et al. (1986) · PubMed · Cited by 20
Lau, Y., Fung, Y. K., Trobough, K. L., Cashman, J., & Wilson, J. A. (1991) · PubMed · Cited by 15
Systemic Administration of Proteasome Inhibitor Protects Against MPTP Neurotoxicity in Mice
Oshikawa, T., Kuroiwa, H., Yano, R., Yokoyama, H., Kadoguchi, N., Kato, H., & Araki, T. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9402-6 · Cited by 14
Kadoguchi, N., Kimoto, H., Yano, R., Kato, H., & Araki, T. (2008) · Metabolic Brain Disease · doi:10.1007/s11011-008-9082-9 · Cited by 14
Proteasome Inhibitor Does Not Enhance MPTP Neurotoxicity in Mice
Kadoguchi, N., Umeda, M., Kato, H., & Araki, T. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9271-4 · Cited by 13
Meredith, G. E., Dervan, A. G., & Totterdell, S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-28066-9_32 · Cited by 10
Self-citationLangston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
Vermot, A., Petit-Härtlein, I., Smith, S. M. E., & Fieschi, F. (2021) · Antioxidants · doi:10.3390/antiox10060890 · Cited by 766
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
Rocha, E. M., De Miranda, B., & Sanders, L. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.004 · Cited by 762
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
Nissanka, N., & Moraes, C. T. (2018) · FEBS Letters · doi:10.1002/1873-3468.12956 · Cited by 444
Metadata
- Authors
- Meredith, G. E., & Rademacher, D. J.
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2011-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 19-33
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W1505937405
- Cited by
- 514
- References
- 148
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.